OrthoPediatrics Corp financials

KIDS CIK 0001425450

Source: EDGAR filings · Built 2026-06-02T03:23:03Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -15.96M -41.31M -43.92M -31.80M -21.17M -29.03M
EBITDA -18.12M -15.93M -9.37M -12.30M -7.34M -18.75M
Working Capital 210.22M 203.21M 184.83M 195.85M 103.93M 123.40M
Net Debt 98.45M 41.44M -18.99M -7.83M -6.30M -27.58M
Gross Margin 73.05% 72.58% 74.80% 74.14% 74.86% 77.42%
Operating Margin -16.60% -17.10% -17.99% -20.77% -18.38% -37.64%
Net Margin -16.78% -18.47% -14.10% 1.03% -16.58% -46.35%
Return on Equity (ROE) -11.44% -10.67% -5.56% 0.33% -7.21% -14.03%
Return on Assets (ROA) -7.80% -7.99% -4.78% 0.29% -5.34% -10.28%
Current Ratio 5.55× 6.98× 5.44× 7.34× 4.50× 4.52×
Debt-to-Equity 0.34× 0.24× 0.03× 0.00× 0.01× 0.01×
Effective Tax Rate -1.17% 9.80% 1.59% 134.10% 6.49% 2.15%
Cash Conversion Ratio 0.12× 0.72× 1.29× -17.30× 0.80× 0.56×
Accruals Ratio -0.07× -0.02× 0.01× 0.05× -0.01× -0.04×
SBC % of Revenue 7.52% 6.62% 7.08% 5.46% 5.96% 8.72%
CapEx Coverage -0.44× -1.90× -1.60× -2.17× -1.61× -1.76×
Free Cash Flow Per Share $-0.68 $-1.79 $-1.94 $-1.52 $-1.10 $-1.61

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 662.17×
P/S 1.89× 2.74× 5.11× 7.43× 12.01× 11.35×
P/B 1.29× 1.58× 2.02× 2.40× 5.23× 3.44×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 236.35M 204.73M 148.73M 122.29M 98.05M 71.08M
Revenues 98.05M 71.08M
Cost of Goods and Services Sold 63.69M 56.13M 37.48M 31.63M 24.65M 16.05M
Gross Profit 172.66M 148.60M 111.25M 90.66M 73.40M 55.03M
Research and Development Expense 9.10M 11.03M 10.89M 8.45M 5.54M 5.27M
Operating Expenses 211.90M 183.61M 138.00M 116.06M 91.43M 81.79M
Operating Income (Loss) -39.24M -35.01M -26.75M -25.40M -18.02M -26.75M
Income Tax Expense (Benefit) 460.00K -4.11M -338.00K -4.95M -1.13M -723.00K
Net Income (Loss) Attributable to Parent -39.65M -37.82M -20.97M 1.26M -16.26M -32.94M
Earnings Per Share, Basic $-1.69 $-1.64 $-0.92 $0.06 $-0.84 $-1.82
Weighted Average Number of Shares Outstanding, Basic 23.46M 23.08M 22.68M 20.70M 19.27M 18.06M
Earnings Per Share, Diluted $-1.69 $-1.64 $-0.92 $0.06 $-0.84 $-1.82
Weighted Average Number of Shares Outstanding, Diluted 23.46M 23.08M 22.68M 20.95M 19.27M 18.06M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 19.56M 43.82M 31.05M 8.99M 7.64M 28.76M
Assets, Current 256.42M 237.17M 226.50M 226.72M 133.65M 158.43M
Assets 508.63M 473.21M 438.75M 427.73M 304.27M 320.41M
Long-term Debt 106.01M 77.48M 11.06M 907.00K 1.04M 1.18M
Liabilities, Current 46.20M 33.96M 41.67M 30.87M 29.71M 35.03M
Long-term Debt, Excluding Current Maturities 99.82M 72.96M 9.91M 763.00K 907.00K 1.04M
Liabilities 162.03M 118.64M 61.72M 49.08M 78.91M 85.64M
Stockholders' Equity Attributable to Parent 346.60M 354.57M 377.02M 378.65M 225.37M 234.77M
Common Stock, Shares, Outstanding 25.09M 24.22M 23.38M 22.88M 19.68M 19.56M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -4.85M -27.05M -27.05M -21.77M -13.06M -18.53M
Payments to Acquire Property, Plant, and Equipment 11.11M 14.26M 16.88M 10.03M 8.10M 10.50M
Net Cash Provided by (Used in) Investing Activities -43.63M -13.16M 41.68M -113.37M -7.41M -69.69M
Net Cash Provided by (Used in) Financing Activities 23.98M 53.13M 7.30M 135.97M 6.00K 46.73M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (KIDS CIK 0001425450), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

HCA

HCA Healthcare, Inc.

RCAT

Red Cat Holdings, Inc.

ASMB

ASSEMBLY BIOSCIENCES, INC.